Survivors of childhood cancer—there is an estimated 500,000 of them in the United States—have an increased risk of experiencing disabling conditions, both from the cancer itself and from the effects of treatment, says a new report from the National Academies of Sciences, Engineering, and Medicine.
The report, Childhood cancer and functional impacts across the care continuum, examines clinical trial participation and advances in treatment, both of which have implications for improving patient outcomes and quality of life. Professor and associate dean for heath affairs Barbara Jones was a member of the committee that authored the report.